Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...

WEX Inc (NYSE:WEX) is set to release its Q4 2024 earnings on Feb 6, 2025. The consensus estimate for Q4 2024 revenue is ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

After falling behind Taiwan Semiconductor Manufacturing (NYSE: TSM) in process technology, Intel embarked on an ambitious and ...

AAK AB reported its Q4 2024 earnings, revealing a robust 11% growth in operating profit compared to the same quarter last year. Despite these strong financial results, the company's stock fell by 6.72 ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Despite growth in ads, Alphabet’s shares sank in pre-market trading as investors digested the company’s revenue miss.

TotalEnergies reported higher-than-expected fourth-quarter earnings, driven by strong performance in its LNG business, ...

The fund outperformed the Russell 2000 Growth Index benchmark in the fourth quarter. The fund fared better than its benchmark ...

Marsh attributed the decline to increasing competition in the commercial property insurance market, stabilization in financial lines, moderation of casualty rate increases, and further reductions in ...

LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...

French oil major TotalEnergies reported a 15% drop in fourth quarter earnings on Wednesday, closing out a year marked by low ...